Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: Proposal of a postoperative NAFLD scoring system

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 17, Issue 3, 2010, Pages 296-304

  Kato, Hiroyuki ^a   Isaji, Shuji ^a   Azumi, Yoshinori ^a   Kishiwada, Masashi ^a   Hamada, Takashi ^a   Mizuno, Shugo ^a   Usui, Masanobu ^a   Sakurai, Hiroyuki ^a   Tabata, Masami ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Liver steatosis; Pancreatectomy; Pancreatic dysfunction

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIARRHEA; FEMALE; HUMAN; INCIDENCE; INTRAOPERATIVE PERIOD; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD; PREVALENCE; RISK FACTOR; SCORING SYSTEM; ADENOCARCINOMA; AGED; COMPUTER ASSISTED TOMOGRAPHY; FATTY LIVER; HOSPITALIZATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITIONAL STATUS; PANCREAS TUMOR; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; RADIOGRAPHY; REVIEW;

GASTROINTESTINAL AGENT; PANCREATIN;

ADENOCARCINOMA; AGED; DIARRHEA; FATTY LIVER; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITIONAL STATUS; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PANCREATIN; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77955880496     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-009-0187-2     Document Type: Article

References (31)

1. Kuczmarski RJ, Carroll MD, Flegal KM, Triano RP. Varing body mass index cutoff points to describe overweight prevalence among US adults: NHANES III (1988-1994). Obes Res. 1997;5: 542-8.
2. Kopelman PG. Obesity as a medical problem. Nature. 2000;404: 635-43. (Pubitemid 30205068)
3. Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis. 2001;21:17-26. (Pubitemid 32240483)
4. Day CP. Non-alcoholic steatohepatitis (NASH): where are we now and where are we going? Gut. 2002;50:585-8.
5. Shen L, Fan JG, Shao Y, Zeng MD, Wang JR, Luo GH, et al. Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. World J Gastroenterol. 2003;9:1106-10. (Pubitemid 36681689)
6. Chitturi S, Farrell GC, George J. Non-alcoholic steatohepatitis in the Asian-Pacific region: future shock? J Gastroenterol Hepatol. 2004;19:368-74.
7. Kawarada Y, Nakamura K, Kida H, Kita T, Mizumoto R, et al. Problems for a long period of management after pancreaticoduodenectomy-Especially changes of exocrine function of the pancreas and pathophysiological changes after gastrectomy (in Japanese). Nippon Syokakigeka Gakkaizasshi (Jpn J Gastroenterol surg). 1988;21:2496-500.
8. Mizumoto R, Iwasaki M. Clinics in fatty liver disease. Kan Tan Sui. 1982;5:607-13. (in Japanese).
9. Tanaka N, Horiuchi A, Yokoyama T, Kawa S, Kiyosawa K, et al. Pancreatic exocrine insufficiency: a rare cause of nonalcoholic steatohepatitis. Am J Gastroenterol. 2008;103:245-6.
10. Ricci C, Longo R, Gioulis E, Bosco M, Pollesello P, Masutti F, et al. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol. 1997;27:108-13. (Pubitemid 27357063)
11. Pamilo M, Sotaniemi EA, Suramo I, Lahde S, Arranto AJ. Evaluation of liver steatotic and fibrous content by computerized tomography and ultrasound. Scand J Gastroenterol. 1983;18:743-7. (Pubitemid 13005020)
12. Hamer OW, Aguirre DA, Casola G, Sirlin CB. Imaging features of perivascular fatty infiltration of the liver: initial observations. Radiology. 2005;237:159-69. (Pubitemid 41346160)
13. Butturini G, Daskalaki D, Molinari E, Scopelliti F, Casarotto A, Bassi C. Pancreatic fistula: definition and current problems. J Hepatobiliary Pancreat Surg. 2008;15:247-51. (Pubitemid 351818762)
14. Shinchi H, Takao S, Maemura K, Aikou T. A new technique for pancreaticogastrostomy for the soft pancreas: the transfixing suture method. J Hepatobiliary Pancreat Surg. 2006;13:212-7.
15. Sari YS, Koç O, Tunali V, Tomaoǧlu K. Choice of the optimal pancreaticojejunal anastomosis technique: how can we improve patient safety in pancreatic surgery? J Hepatobiliary Pancreat Surg. 2008;15:479-82.
16. Poon RT, Fan ST, Lo CM, Ng KK, Yuen WK, Yeung C, Wong J. Ann Surg 2007; 246:425-33 (discussion 433-5).
17. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis. 2001;21:3-16. (Pubitemid 32240482)
18. Allard JP. Other disease associations with non-alcoholic fatty liver disease (NAFLD). Best Pract Res Clin Gastroenterol. 2002;16:783-95.
19. Isaji S. Nutritional change and management at the long-term period after major pancreatectomy. Eiyo Hyoka to chiryo (JPN J Nutritional Assessment). 2006;23:34-8. (in Japanese).
20. Mizumoto R, Kawarada Y, Goshima H, Tamaki H, Sekoguchi T, Tomikawa I. Carbohydrate metabolism and endocrine function in the pancreas remnant after major pancreatic resection. Am J Surg. 1982;143:237-43. (Pubitemid 12154599)
21. Chitturi S, Farrell G. Ethiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis. 2001;21:27-41.
22. Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med. 2000;343:1467-76.
23. Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, Cummins AG. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor β in the pathogenesis of nonalcoholic steatohepatitis. Gut. 2001;48:206-11. (Pubitemid 32141844)
24. Oliveira CP, da Costa Gayotto LC, Tatai C, Della Bina BI, Janiszewski M, Lima ES, et al. Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet. J Cell Mol Med. 2002;6:399-406. (Pubitemid 44133960)
25. Griffin IJ, Kim SC, Hicks PD, Liang LK, Abrams SA. Zinc metabolism in adolescents with Crohn's disease. Pediatr Res. 2004;56:235-9.
26. Sturniolo GC, Fries W, Mazzon E, Di Leo V, Barollo M, D'inca R. Effect of zinc supplementation on intestinal permeability in experimental colitis. J Lab Clin Med. 2002;139:311-5. (Pubitemid 34577483)
27. Hennig B, Wang Y, Ramasamy S, McClain CJ. Zinc deficiency alters barrier function of cultured porcine endothelial cells. J Nutr. 1992;122:1242-7.
28. Kato K, Isaji S, Kawarada Y, Hibasami H, Nakashima K. Effect of zinc administration on pancreatic regeneration after 80% pancreatectomy. Pancreas. 1997;14:158-65. (Pubitemid 27106103)
29. Bydder GM, Chapman RW, Harry D, Bassan L, Sherlock S, Kreel L. Computed tomography attenuation values in fatty liver. J Comput Tomogr. 1981;5:33-5. (Pubitemid 11075771)
30. Ricci C, Longo R, Gioulis E, Bosco M, Pollesello P, Masutti F, et al. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol. 1997;27:108-13. (Pubitemid 27357063)
31. Pamilo M, Sotaniemi EA, Suramo I, Lahde S, Arranto AJ. Evaluation of liver steatotic and fibrous content by computerized tomography and ultrasound. Scand J Gastroenterol. 1983;18:743-7. (Pubitemid 13005020)